CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Prasugrel hydrochloride

Last Updated: May 5, 2010
Result type: Reports
Project Number: SR0200-000
Product Line: Reimbursement Review

Generic Name: Prasugrel hydrochloride

Brand Name: Effient

Manufacturer: Eli Lilly Canada Inc.

Therapeutic Area: Acute Coronary Syndrome

Indications: Acute Coronary Syndrome (ACS)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: February 16, 2011

Recommendation Type: Do not list